logo

For the Inventor, By the Inventor

Paris, France

Invectys

Calculating rank
USPTO Granted Patents = 10

% Expired Patents = 30.0


Forward Citations = 13

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal Pierre Langlade Demoyen (9 out of 17 patents)

silverMedal Christelle Liard (6 out of 6 patents)

bronzeMedal Simon Wain-Hobson (6 out of 41 patents)

4.  Thierry Huet (3 out of 6 patents)

5.  Elodie Pliquet (2 out of 3 patents)

6.  Olivier Adotevi (2 out of 2 patents)

7.  Magalie Dosset (2 out of 2 patents)

8.  Julien Caumartin (1 out of 8 patents)

9.  Pierre Langlade-Demoyen (1 out of 8 patents)

10.  Jessie Thalmensi (1 out of 1 patent)

11.  Christophe Calvet (1 out of 1 patent)

12.  Anna Kostrzak (1 out of 1 patent)

13.  Maria De Las Nieves Loustau (1 out of 1 patent)

14.  Luis Maria Mir (1 out of 3 patents)

15.  Luis M Mir (0 patent)


10 patents:

1. 12064474 - Telomerase encoding DNA vaccine (2024-08-20),
2. 10695409 - Universal cancer peptides derived from telomerase (2020-06-30),
3. 10675337 - Cancer vaccine for cats (2020-06-09),
4. 10493154 - Gene electrotransfer into skin cells (2019-12-03),
5. 10183065 - Telomerase encoding DNA vaccine (2019-01-22),
6. 10138488 - Cancer vaccine for dogs (2018-11-27),
7. 10010591 - Method of treating fibrosarcoma using a nucleic acid sequence encoding APOBEC3A (2018-07-03),
8. 10005845 - Antibodies and fragments thereof raised against the alpha-3 domain of HLA-G protein, methods and means for their preparation, and uses thereof (2018-06-26),
9. 9931387 - Cancer vaccine for cats (2018-04-03),
10. 9669080 - Universal cancer peptides derived from telomerase (2017-06-06),
Company Overview
Invectys is a biotechnology company based in Paris, specializing in the development of innovative immunotherapies for cancer treatment. The organization focuses on harnessing the power of the immune system to target and eliminate cancer cells, utilizing advanced research in cellular and molecular biology. With a commitment to addressing unmet medical needs, Invectys aims to improve patient outcomes through its cutting-edge therapeutic approaches, contributing to the evolving landscape of cancer care.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

10 Patents

#362 in Paris

#1,711 in France

#56,119 in the World

Paris, FR
Paris, France

Invectys

Forward Citations = 13

14 inventors:

goldMedal Pierre Langlade Demoyen (9 out of 17 patents)

silverMedal Christelle Liard (6 out of 6 patents)

bronzeMedal Simon Wain-Hobson (6 out of 41 patents)

4.  Thierry Huet (3 out of 6 patents)

5.  Elodie Pliquet (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Invectys. Retrieved from https://idiyas.com/company/invectys

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…